As of 2024-12-11, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 16.6x | 15.0x |
| Forward P/E multiples | 15.1x - 17.8x | 15.9x |
| Fair Price | (18.43) - (20.25) | (18.88) |
| Upside | -180.1% - -188.0% | -182.0% |
| Date | EV/EBITDA |